124985906	124985906	CD	B-NP	O
|	|	NN	I-NP	O
SIUOMC	SIUOMC	NN	I-NP	O
|	|	NN	I-NP	O
26155083	26155083	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3871004	3871004	CD	B-NP	O
|	|	CC	I-NP	O
5/1/2005	5/1/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
endometrial	endometrial	JJ	I-NP	O
caRCINOMA	caRCINOMA	NN	I-NP	O
|	|	NN	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/7/2005	7/7/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/15/2005	7/15/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
TORTU	TORTU	NNP	B-NP	O
,	,	,	O	O
IGNACIO	IGNACIO	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
Gynecologic	Gynecologic	NNP	B-NP	O
Oncology	Oncology	NNP	I-NP	O
.	.	.	O	O

DIAGNOSIS	DIAGNOSIS	NN	B-NP	O
:	:	:	O	O
Endometrial	Endometrial	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Czaplewski	Czaplewski	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
76-year-old	76-year-old	JJ	I-NP	O
G6	G6	NN	I-NP	O
,	,	,	O	O
P3	P3	NN	B-NP	B-DNA
with	with	IN	B-PP	O
postmenopausal	postmenopausal	JJ	B-NP	O
bleeding	bleeding	NN	I-NP	O
.	.	.	O	O

Endometrial	Endometrial	JJ	B-NP	O
biopsy	biopsy	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
grade	grade	NN	B-NP	O
II	II	CD	I-NP	O
endometrioid-type	endometrioid-type	JJ	I-NP	O
adenocarcinoma	adenocarcinoma	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
endometrium	endometrium	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
opted	opte	VBD	B-VP	O
for	for	IN	B-PP	O
surgical	surgical	JJ	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
OB	OB	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
G6	G6	NN	B-NP	O
,	,	,	O	O
P3	P3	NN	B-NP	B-DNA
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBD	I-VP	O
three	three	CD	B-NP	O
spontaneous	spontaneous	JJ	I-NP	O
vaginal	vaginal	JJ	I-NP	O
deliveries	delivery	NNS	I-NP	O
and	and	CC	O	O
three	three	CD	B-NP	O
spontaneous	spontaneous	JJ	I-NP	O
abortions	abortion	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
postmenopausal	postmenopausal	JJ	B-ADJP	O
since	since	IN	B-PP	O
age	age	NN	B-NP	O
55	55	CD	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
STD	STD	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
cervical	cervical	JJ	B-NP	O
dysplasia	dysplasia	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Diabetes	Diabete	NNS	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	I-NP	O
arthritis	arthritis	NN	I-NP	O
and	and	CC	I-NP	O
obesity	obesity	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
CABG	CABG	NN	I-NP	B-protein
in	in	IN	B-PP	O
April	April	NNP	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
umbilical	umbilical	JJ	B-NP	O
hernia	hernia	NN	I-NP	O
repair	repair	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Glyburide	Glyburide	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
metformin	metformin	NN	B-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Toprol-XL	Toprol-XL	NNP	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
nightly	nightly	RB	B-ADVP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
tobacco	tobacco	NN	I-NP	O
or	or	CC	I-NP	O
drugs	drug	NNS	I-NP	O
.	.	.	O	O

Occasional	Occasional	JJ	B-NP	O
alcohol	alcohol	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
GYN	GYN	NN	I-NP	O
cancers	cancer	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
on	on	IN	B-PP	O
7/7/2005	7/7/2005	CD	B-NP	O
,	,	,	O	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
total	total	JJ	I-NP	O
abdominal	abdominal	JJ	I-NP	O
hysterectomy	hysterectomy	NN	I-NP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
salpingo-oophorectomy	salpingo-oophorectomy	NN	I-NP	O
and	and	CC	I-NP	O
staging	staging	NN	I-NP	O
.	.	.	O	O

Intraoperative	Intraoperative	JJ	B-ADJP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
ovarian	ovarian	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

Estimated	Estimate	VBN	B-NP	O
blood	blood	NN	I-NP	O
loss	loss	NN	I-NP	O
was	be	VBD	B-VP	O
600	600	CD	B-NP	O
mL	mL	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
see	see	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Boris	Boris	NNP	I-NP	O
Androlewicz	Androlewicz	NNP	I-NP	O
separate	separate	JJ	I-NP	O
dictation	dictation	NN	I-NP	O
for	for	IN	B-PP	O
full	full	JJ	B-NP	O
details	detail	NNS	I-NP	O
.	.	.	O	O

POSTOPERATIVE	POSTOPERATIVE	NN	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Relatively	Relatively	RB	B-ADJP	O
uncomplicated	uncomplicated	JJ	I-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
ileus	ileus	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
NG	NG	NN	I-NP	O
tube	tube	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
10/4/2005	10/4/2005	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
became	become	VBD	B-VP	O
tachypneic	tachypneic	JJ	B-ADJP	O
,	,	,	O	O
tachycardic	tachycardic	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
developed	develop	VBD	B-VP	O
cough	cough	NN	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
suspicious	suspicious	JJ	B-ADJP	O
for	for	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
with	with	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
clindamycin	clindamycin	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
oxygen	oxygen	NN	I-NP	O
requirement	requirement	NN	I-NP	O
of	of	IN	B-PP	O
3	3	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
O2	O2	NN	B-NP	B-protein
.	.	.	O	O

During	During	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
the	the	DT	B-NP	O
Diabetes	Diabetes	NNP	I-NP	O
Service	Service	NNP	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
her	her	PRP	B-NP	O
and	and	CC	O	O
make	make	VB	B-VP	O
recommendations	recommendation	NNS	B-NP	O
regarding	regard	VBG	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
postop	postop	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
8	8	CD	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
wound	wound	JJ	I-NP	O
drainage	drainage	NN	I-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
staples	staple	NNS	I-NP	O
were	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
serous	serous	JJ	I-NP	O
drainage	drainage	NN	I-NP	O
.	.	.	O	O

Wound	Wound	NN	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
packed	pack	VBN	I-VP	O
,	,	,	O	O
wound	wound	NN	B-NP	O
was	be	VBD	B-VP	O
further	further	RB	I-VP	O
opened	open	VBN	I-VP	O
and	and	CC	O	O
packed	pack	VBN	B-VP	O
with	with	IN	B-PP	O
sterile	sterile	JJ	B-NP	O
gauze	gauze	NN	I-NP	O
,	,	,	O	O
soaked	soak	VBD	B-VP	O
in	in	IN	B-PP	O
saline	saline	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
VNA	VNA	NN	B-NP	B-protein
for	for	IN	B-PP	O
b.i.d.	b.i.d.	NN	B-NP	O
wound	wound	NN	I-NP	O
packing	packing	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
new	new	JJ	B-NP	O
medications	medication	NNS	I-NP	O
namely	namely	RB	B-ADVP	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
20	20	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
b.i.d.	b.i.d.	VBN	B-VP	O
with	with	IN	B-PP	O
recommendation	recommendation	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
early	early	JJ	I-NP	O
follow	follow	NN	I-NP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
notified	notify	VBN	I-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
medications	medication	NNS	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Lasix	Lasix	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
human	human	JJ	I-NP	I-protein
20	20	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
Flagyl	Flagyl	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
renally	renally	RB	I-VP	O
dosed	dose	VBN	I-VP	O
,	,	,	O	O
oxycodone	oxycodone	NN	B-NP	O
5-10	5-10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
nightly	nightly	RB	I-ADVP	O
,	,	,	O	O
Atrovent	Atrovent	JJ	B-NP	O
nebulizers	nebulizer	NNS	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
Ambien	Ambien	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
nightly	nightly	RB	I-ADVP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
750	750	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
renally	renally	RB	B-ADVP	O
dose	dose	NN	B-NP	O
and	and	CC	O	O
Toprol-XL	Toprol-XL	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Nordeen	Nordeen	NNP	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
nurse	nurse	NN	I-NP	O
for	for	IN	B-PP	O
staple	staple	NN	B-NP	O
removal	removal	NN	I-NP	O
and	and	CC	O	O
then	then	RB	O	O
routine	routine	JJ	B-NP	O
postop	postop	NN	I-NP	O
follow	follow	VBP	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Craner	Craner	NNP	I-NP	O
within	within	IN	B-PP	O
two	two	CD	B-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
weeks	week	NNS	I-NP	O
in	in	IN	B-PP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
primary	primary	JJ	B-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
early	early	JJ	B-NP	O
next	next	JJ	I-NP	O
week	week	NN	I-NP	O
to	to	TO	B-VP	O
review	review	VB	I-VP	O
her	her	PRP$	B-NP	O
diabetes	diabetes	NN	I-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
written	write	VBN	B-NP	O
discharge	discharge	NN	I-NP	O
instructions	instruction	NNS	I-NP	O
with	with	IN	B-PP	O
phone	phone	NN	B-NP	O
numbers	number	NNS	I-NP	O
to	to	TO	B-VP	O
contact	contact	VB	I-VP	O
in	in	IN	B-PP	O
case	case	NN	B-NP	O
of	of	IN	B-PP	O
questions	question	NNS	B-NP	O
or	or	CC	I-NP	O
concerns	concern	NNS	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
9-6187272	9-6187272	CD	B-NP	O
BFFocus	BFFocus	NN	I-NP	O
Dictated	Dictate	VBD	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
HIGA	HIGA	NN	B-NP	B-protein
,	,	,	O	O
STEWART	STEWART	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
YOUNKINS	YOUNKINS	NNS	B-NP	O
,	,	,	O	O
SIMON	SIMON	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
9917139	9917139	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
7/18/05	7/18/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
7/18/05	7/18/05	CD	B-NP	O

